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Purpose: To evaluate the impact of nocturia on health-related quality of life and sleep in men.
Methods: From January 2008 to December 2008, 284 patients with lower urinary tract symptoms were selected for this study. 
The participants completed a series of questionnaires on health-related quality of life (the overactive bladder questionnaire, or 
OAB-q), the Medical Outcomes Study (MOS) sleep scale, and the frequency volume chart.
Results: The patient population had a mean age of 60.0±13.4 years (range, 40 to 79 years). The mean duration of symptoms was 
28.8±34.6 months. The mean number of voiding episodes per night was measured as follows: 88 patients (31.0%) reported no 
nocturia, 60 patients (21.1%) reported 2>voids/night ≥1, 56 patients (19.7%) reported 3>voids/night ≥2, and 80 patients (28.2%) 
reported ≥3 voids/night. The mean number of nocturia episodes increased with age (P=0.001), and the number of nocturia 
episodes was significantly associated with the OAB-q symptom score (P=0.001) and symptom bother (P=0.001). Among the 
categories of the MOS sleep scale, sleep index I (P=0.020), sleep disturbance (P=0.010), adequacy of sleep (P=0.005), and som-
nolence (P=0.041) were significantly associated with an increased number of nocturia episodes. 
Conclusions: The number of nocturia episodes increased with age in men. Nocturia appeared to be associated with further neg-
ative effects on sleep quality, health-related quality of life, and symptom bother. 
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INTRODUCTION
Nocturia, one of the most prevalent urinary symptoms in adults, 
is regarded as having a significant impact on sleep and quality 
of life [1]. According to the definition of the International Con-
tinence Society, nocturia is the complaint that an individual 
wakes one or more times to void urine at night [2]. In a nation-
wide Asian epidemiologic study, Homma et al. [3] reported that 
nighttime frequency of voiding was the most bothersome symp-
tom among various lower urinary tract symptoms (LUTS). 
  Asplund and Aberg [4] also reported that nocturia can cause 
daytime fatigue, decreased general well-being, and increased 
risk of nighttime falling. Fragmented and disturbed sleep pat-
terns may be observed in patients with nocturia that can result 
in disturbance of good sleep and daytime sleepiness and result 
in serious health risks in this population [5]. Middelkoop et al. 
[6] suggested that nocturia is a main factor of disturbance of 
sleep maintenance in adults aged 50 years or older. Su et al. [7] 
reported that nocturia increases the risk of insomnia 20.6-fold. 
Therefore, it is important to determine how much of an impact 
nocturia has on sleep quality and health-related quality of life 
and how they are correlated with each other. The aim of the 
present study was therefore to evaluate the effects of nocturia 
on sleep and health-related quality of life.
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This study was conducted from January 2008 to December 2008 
among patients who visited our outpatient clinic with LUTS. All 
patients underwent a detailed clinical evaluation involving a 
complete history taking, a physical examination, a digital rectal 
examination, completion of the International Prostate Symptom 
Score (IPSS), urinalysis, and measurement of prostate-specific 
antigen. A total of 284 subjects who were aged >40 years, had 
moderate to severe LUTS (IPSS sum >8), and postvoid residual 
urine <100 mL were included. Participants completed a series 
of questionnaires on health-related quality of life (validated Ko-
rean version of the overactive bladder questionnaire, or OAB-
q), the Medical Outcomes Study (MOS) sleep scale, and a fre-
quency volume (FV) chart.
  Subjects with a confused or depressed mental status, taking 
medication such as sedatives or tranquillizers, taking medica-
tions that may alter or control bladder symptoms and sleep 
quality, with a history of a previous surgery for LUTS, with a 
history of urinary retention, or with symptomatic urinary tract 
infection, uropathologic conditions such as urinary stones and 
urogenital cancer, or neurogenic bladder were not included. Pa-
tients with symptoms of urinary incontinence or restricted mo-
bility and patients who worked at night were also excluded from 
this analysis. All patients signed an informed consent agreement.
Frequency Volume Chart 
Patients were asked to complete 3-day FV charts. They were 
taught how to precisely complete the FV charts by the urologist 
and were asked not to alter their usual fluid intake and voiding 
habits during the study. The times that they arose in the morn-
ing and went to bed at night were recorded on the FV charts. 
Numbers and volumes of voids were estimated by taking a mean 
over the 3-day study period. Nighttime was defined as the time 
from bedtime to rising in the morning. 
Overactive Bladder Questionnaire
The OAB-q is a 33-item self-administered symptom bother scale 
that assesses the patient’s current bladder condition; the first 8 
items assess symptom bother and the remaining 25 items assess 
health-related quality of life. Domains include coping, concern, 
sleep, and social interaction [8].
Medical Outcome Study Sleep Scale
The MOS sleep scale yields a sleep problems index and six scale 
scores: sleep disturbance (have trouble falling asleep, how long 
to fall asleep, sleep was not quiet, awaken during your sleep time, 
and have trouble falling asleep again), sleep adequacy (get 
enough sleep to feel rested upon waking in the morning, get the 
amount of sleep needed), daytime somnolence (drowsy during 
the day, have trouble staying awake during the day, take naps), 
snoring, awaken with shortness of breath or with headache, and 
quantity of sleep [9]. Quantity of sleep is scored as the average 
number of hours slept per night. The other scales and problems 
index are scored on a possible range of from 0 to 100, and high-
er scores indicate more of the concept being measured.
Statistical Analysis
For statistical analysis, patients were stratified by age groups and 
number of nocturia episodes. Data were compared statistically 
by using analysis of variance. A 5% level of significance was es-
tablished for all of the statistical testing. Statistical analysis was 
performed by using SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
Patient characteristics are listed in Table 1. The patient popula-
tion had a mean age of 60.0±13.4 years (range, 40 to 79 years). 
The mean duration of symptoms was 28.8±34.6 months. The 
incidences of hypertension and cardiovascular disease were 
Table 1. Patient characteristics and comorbidities
Characteristics Value
No. of patients 284
Mean age (yr) 60.0±13.4
Duration of symptom (mo) 28.8±34.6
Additional combinded disease
Hypertention 70 (24.6)
Diabetus mellitus 52 (18.3)
Cardiovascular disease 20 (7.0)
Others 6 (2.1)
No. of nocturia
Nocturia < 1 88 (31.0)
2 > Nocturia ≥ 1 60 (21.1)
3 > Nocturia ≥ 2 56 (19.7)
Nocturia ≥ 3 80 (28.2)
Values are presented as mean±SD or number (%).84    www.einj.or.kr
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24.6% and 18.3%, respectively (Table 1). The mean number of 
voiding episodes per night was measured as follows: 88 patients 
(31.0%) reported no nocturia, 60 patients (21.1%) reported 
2>voids/night ≥1, 56 patients (19.7%) reported 3>voids/night 
≥2, and 80 patients (28.2%) reported ≥3 voids/night (Table 1).
  The mean number of nocturia episodes increased with age 
(P=0.001, Table 2). The number of nocturia episodes was sig-
nificantly associated with the OAB-q symptom score (P=0.001) 
and symptom bother (P=0.001, Table 3). Among the categories 
of the MOS sleep scale, sleep index 1 (P=0.020), sleep distur-
bance (P=0.010), adequacy of sleep (P=0.005), and somno-
lence (P=0.041) were significantly associated with an increased 
number of nocturia episodes (Table 4). 
DISCUSSION 
In the present study, we evaluated the impact of nocturia on 
health-related quality of life and quality of sleep in men. Over-
all, we found that the prevalence of nocturia increased with age. 
Furthermore, nocturia was significantly associated with a de-
creased quality of life symptom score and symptom bother on 
the OAB-q and decreased sleep quality on the MOS sleep scale. 
Among the several categories of the MOS sleep scale, sleep in-
dex I, sleep disturbance, adequacy of sleep, and somnolence were 
significantly associated with an increased number of nocturia 
episodes. Given the impact of nocturia on these health-related 
quality of life indexes and sleep, nocturia should be routinely 
assessed by urologic clinicians and should be treated with con-
sideration of its impact on these symptoms. 
  According to the definition of the International Continence 
Society, nocturia is the complaint that an individual has to awak-
en at night one or more times to void urine [2]. Nocturia has 
been recognized as a discrete clinical condition rather than a 
simple symptom. Nocturia has a negative impact on quality of 
life, affecting both morbidity and mortality. Many studies have 
examined the influence of nocturia on well-being and quality 
of life and have shown a consistently high impact of nocturia 
Table 2. Age related classification of nocturia
Age (yr) No. of patients (%)
No. of nocturia 
(mean±SD) P-value
40-49 60 (21.1) 0.96±1.22 0.001
50-59 67 (23.6) 1.31±2.00
60-69 105 (37.0) 2.24±1.34
≥70 52 (18.3) 2.63±2.07
P-values calculated with analysis of variance.
Table 3. Quality of life and symptom bother according to nocturia 
No nocturia 2> Nocturia ≥1 3> Nocturia ≥2 Nocturia ≥3 P-value
Mean age 53.6±14.8 55.6±14.3 62.3±10.3 67.0±9.4 0.001
HRQoL total 85.5±12.6 83.0±13.3 76.4±22.4 65.2±22.6 0.001
Symptom bother 23.8±20.7 25.2±21.9 30.8±23.8 46.2±27.5 0.001
HRQoL, health related Quality of Life.
P-values calculated with analysis of variance.
Table 4. Sleep quality according to nocturia
MOS sleep scale No nocturia 2> nocturia ≥1 3> nocturia ≥2 Nocturia ≥3 P-value
Sleep index I 31.5±16.2 33.9±17.3 36.9±17.0 43.1±17.1 0.020
Hours sleep/night 6.1±1.4 6.7±1.4 6.3±1.6 6.2±1.6 0.519
Sleep disturbance 29.9±18.5 31.6±22.4 33.5±22.2 45.8±20.5 0.010
Snoring 38.8±28.7 39.3±24.9 37.9±27.9 44.5±26.6 0.723
Shortness of breath 19.3±23.2 20.6±27.5 23.6±26.7 26.5±26.9 0.661
Adequacy of sleep 39.7±20.5 42.6±20.8 45.5±23.5 48.5±22.5 0.005
Somnolence 36.0±16.1 39.2±21.4 42.4±21.9 44.5±18.5 0.041
MOS, Medical Outcomes Study.
P-values calculated with analysis of variance.www.einj.or.kr    85
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on these variables [10]. Nocturia has also been associated with 
an increased risk of falling down, limb fracture, excessive day-
time somnolence, and nocturnal enuresis, when nighttime 
wakening occurs two or more times, with an increased risk of 
from 10 to 21% [11]. The reported impairment of quality of life 
is similar to that of type II diabetes patients complaining of 
nocturia twice or more at night [12]. General well-being is as-
sociated with fewer nighttime voids and better sleep quality, 
and days absent from work in working women due to sickness 
is related to the frequency of nighttime voiding [4]. 
  Quality of life is negatively affected in most individuals who 
experience nocturia; this is perhaps to be expected of a condi-
tion that disrupts healthy sleep patterns. Sleep is essential to all 
biological individuals and is a phenomenon of a physiologic 
state of unconsciousness and inactivity of the voluntary muscles 
[13]. It is suggested that unfragmented sleep, 7 to 8 hours for 
most adults, is necessary for maintenance of physical, mental, 
and emotional well-being [14]. The abnormal sleep patterns 
observed in patients with nocturia can result in sleep depriva-
tion and daytime sleepiness, lack of concentration and coordi-
nation, reduction in creativity, and alteration of mood, which 
may lead to serious health risks in the general population [5,15]. 
As a consequence, nocturia may have clinical implications re-
garding daytime activity and general health status. Sleep distur-
bance caused by nocturnal urinary frequency may result in de-
creased cognitive function during daytime periods, decreased 
performance at work, and depression [16]. A link between sleep 
problems and depression in older men has been observed with 
a stronger relationship noted in association with increasing 
nocturnal frequency [17]. Recently, there has also been some 
evidence to suggest that sleep quality has an impact on general 
immune system and host defense mechanisms, and, thereby, 
that sleep disturbance is associated with increased morbidity 
and mortality [4,18,19].
  In the typical adult, symptoms of nocturia are considered to 
be one of the most common reasons for interrupted sleep. Mid-
dlekoop et al. [6], who examined the way in which nocturia 
symptoms impacted sleep quality in a Dutch cross-sectional 
epidemiologic study, reported that nocturia and worry were the 
most important causes of sleep disturbance in adults over 50 
years of age. The effects of nocturia on sleep disturbance have 
also been investigated in an elderly Swedish population. A close 
link was found between nocturia and sleep quality; nocturia 
was associated with an increased prevalence of sleep disorders, 
poorer quality of sleep, and increased daytime fatigue [4]. More 
recently, Yoshimura et al. [20] conducted a community-based 
study to determine the relationships among nocturia, sleep dis-
turbance, and general health-related quality of life. They con-
firmed that an elevated nighttime frequency markedly reduces 
most aspects of health-related quality of life. They also observed 
that nighttime frequency had a close association with many as-
pects of sleep problems, among other factors, including chronic 
disease. 
  The prevalence of nocturia can increase in a linear fashion in 
association with increasing age, and the bother associated with 
nocturia symptoms also increases [20,21]. In the present study, 
we found consistent results showing an increased mean num-
ber of nocturia episodes with increased age. In addition to the 
age-related physiological changes to lower urinary tract func-
tion, nocturia in the elderly appears to result in a higher daily 
urine production than that in age-matched controls without 
nocturia. There has been a suggestion that these physiological 
changes might lead to an older adult experiencing an increased 
nocturnal urinary frequency [22] and a reduction in functional 
bladder capacity and reduced sensation of bladder filling. Many 
older people tend to have drinking habits that include fluid in-
take late at night, such as alcohol [23]. Diabetes mellitus and 
heart failure can induce polyuria due to raised arterial natri-
uretic peptide levels and an increased drive to thirst. Hypercal-
cemia resulting from oral calcium supplementation, dependent 
edema due to venous stasis or hypoalbuminemia, and diuretic 
medication late in the day causing edema have also been sug-
gested as etiologies of nocturia in the elderly population [24]. 
Nocturia has also been associated with obstructive sleep apnea, 
related to elevated nighttime urine production and atrial natri-
uretic peptide excretion in response to cardiac distension caused 
by negative pressure within the chest. Therefore, a patient’s usu-
al pattern of fluid intake and drinking habits, such as alcohol 
consumption, should be ascertained. A detailed drug history, 
such as diuretics and antihypertensive medication, should be 
taken and counsel should to provided to make alterations if 
possible. Understanding the etiology of nocturia is important 
for appropriate management; however, it can have a complex 
and multifactorial origin.
  There are several limitations to this study. The sample size 
was small and young adults were not included. This study was a 
cross-sectional study and is subject to recall bias. Many impor-
tant variables in this analysis, such as comorbid conditions and 
medications that can affect the condition of the bladder and 
nocturia, were based entirely on participant reports without 86    www.einj.or.kr
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clinical verification. We used the FV chart for 3 days. Also, we 
were not able to check the amount of water drunk by our pa-
tients, who recorded voided volume and the time of each mic-
turition, day and night. Despite these limitations, we believe that 
our study provides some valuable clues for treatment of patients 
with nocturia, with significant consideration for associated sleep 
disturbance. 
  In conclusion, the number of nocturia episodes increased 
with age in men. Nocturia appeared to be associated with fur-
ther negative effects on sleep quality, health-related quality of 
life, and symptom bother. 
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